Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DecNef for AVH in Schizophrenia

NCT: NCT07779226 · NOT_YET_RECRUITING

NCT IDNCT07779226
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2028-03-31
SponsorNew York State Psychiatric Institute (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to learn whether a research neurofeedback training approach done during MRI scans may help reduce hallucinations such as the experience of hearing voices persistent despite treatment.

Frequently Asked Questions

What is DecNef for AVH in Schizophrenia?

DecNef for AVH in Schizophrenia is a clinical trial registered under NCT07779226. Current status: NOT_YET_RECRUITING.

What is the status of NCT07779226?

The current status of NCT07779226 (DecNef for AVH in Schizophrenia) is: NOT_YET_RECRUITING.

When did DecNef for AVH in Schizophrenia start?

DecNef for AVH in Schizophrenia started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.